QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.39%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NYSE:MCK

McKesson Stock Forecast, Price & News

$148.23
-3.90 (-2.56 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$146.46
Now: $148.23▼
$150.00
50-Day Range
$149.66
MA: $152.88▼
$159.90
52-Week Range
$112.60
Now: $148.23▼
$172.18
Volume1.46 million shs
Average Volume2.66 million shs
Market Capitalization$24.04 billion
P/E Ratio26.42
Dividend Yield1.10%
Beta0.77
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Read More
McKesson logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.08 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNYSE:MCK
Previous Symbol
CUSIP58155Q10
CIK927653
Webwww.mckesson.com
Phone972-446-4800

Debt

Debt-to-Equity Ratio1.13
Current Ratio1.00
Quick Ratio0.57

Price-To-Earnings

Trailing P/E Ratio26.42
Forward P/E Ratio9.80
P/E Growth1.59

Sales & Book Value

Annual Sales$231.05 billion
Price / Sales0.10
Cash Flow$20.97 per share
Price / Cash Flow7.07
Book Value$30.01 per share
Price / Book4.94

Profitability

EPS (Most Recent Fiscal Year)$14.95
Net Income$900 million
Net Margins0.40%
Return on Equity42.33%
Return on Assets4.26%

Miscellaneous

Employees80,000
Outstanding Shares162,190,000
Market Cap$24.04 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$148.23
-3.90 (-2.56 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock price been impacted by COVID-19?

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MCK stock has increased by 9.7% and is now trading at $148.23.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of McKesson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for McKesson.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its earnings results on Monday, August, 3rd. The company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.35 by $0.42. The firm earned $55.68 billion during the quarter, compared to the consensus estimate of $54.16 billion. McKesson had a net margin of 0.40% and a return on equity of 42.33%. The company's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.31 earnings per share.
View McKesson's earnings history.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Wednesday, July 29th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.42 per share on Thursday, October 1st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Monday, August 31st. This is an increase from McKesson's previous quarterly dividend of $0.41.
View McKesson's dividend history.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY21 earnings guidance on Monday, August, 3rd. The company provided earnings per share (EPS) guidance of $14.70-15.50 for the period, compared to the Thomson Reuters consensus estimate of $14.39.

What price target have analysts set for MCK?

13 brokers have issued twelve-month price targets for McKesson's stock. Their forecasts range from $147.00 to $204.00. On average, they expect McKesson's share price to reach $179.08 in the next year. This suggests a possible upside of 20.8% from the stock's current price.
View analysts' price targets for McKesson.

Are investors shorting McKesson?

McKesson saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 1,660,000 shares, a decline of 22.4% from the August 15th total of 2,140,000 shares. Based on an average daily volume of 1,090,000 shares, the days-to-cover ratio is presently 1.5 days. Currently, 1.0% of the shares of the stock are short sold.
View McKesson's Short Interest.

Who are some of McKesson's key competitors?

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all competitors.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), Johnson & Johnson (JNJ), AbbVie (ABBV), AT&T (T), Bank of America (BAC), salesforce.com (CRM), NVIDIA (NVDA) and UnitedHealth Group (UNH).

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. John H. Hammergren, Chairman & CEO (Age 60)
  • Britt J. Vitalone, CFO & Exec. VP (Age 50)
  • Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
  • Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
  • Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.90%), Vanguard Group Inc. (8.66%), Nordea Investment Management AB (2.69%), FMR LLC (2.39%), Pzena Investment Management LLC (1.85%) and Bank of New York Mellon Corp (1.31%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and Sundeep G Reddy.
View institutional ownership trends for McKesson.

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Prudential PLC, Pzena Investment Management LLC, FMR LLC, Charles Schwab Investment Management Inc., Prudential Financial Inc., Bank of Montreal Can, and Glenmede Trust Co. NA. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, and Sundeep G Reddy.
View insider buying and selling activity for McKesson.

Which institutional investors are buying McKesson stock?

MCK stock was acquired by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, BlackRock Inc., AQR Capital Management LLC, Senator Investment Group LP, Marshall Wace North America L.P., AJO LP, Bridgeway Capital Management Inc., and Alyeska Investment Group L.P..
View insider buying and selling activity for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $148.23.

How big of a company is McKesson?

McKesson has a market capitalization of $24.04 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.